Cargando…
Novel immune–risk score of gastric cancer: A molecular prediction model combining the value of immune–risk status and chemosensitivity
Gastric cancer is still one of the most common and deadly malignancies in the world. Not all patients could benefit from chemotherapy or chemoradiotherapy due to tumor heterogeneity. Therefore, identifying different subgroups of patients is an important trend for obtaining more effective responses....
Autores principales: | Duan, Shijie, Wang, Pengliang, Liu, Funan, Huang, Hanwei, An, Wen, Pan, Siwei, Wang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537086/ https://www.ncbi.nlm.nih.gov/pubmed/30945466 http://dx.doi.org/10.1002/cam4.2077 |
Ejemplares similares
-
Novel prognostic biomarkers of gastric cancer based on gene expression microarray: COL12A1, GSTA3, FGA and FGG
por: Duan, Shijie, et al.
Publicado: (2018) -
Improved risk scoring systems for colorectal cancer screening in Shanghai, China
por: Wu, Wei‐Miao, et al.
Publicado: (2022) -
Value of incorporating newly identified risk factors into risk prediction for chemotherapy‐induced febrile neutropenia
por: Li, Yanli, et al.
Publicado: (2018) -
Long‐term risk of gastrointestinal cancers in persons with gastric or duodenal ulcers
por: Søgaard, Kirstine K., et al.
Publicado: (2016) -
Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives
por: Abdi, Esmat, et al.
Publicado: (2019)